August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yan Leyfman: Safer CAR T cell therapy for solid tumors
Mar 27, 2025, 04:41

Yan Leyfman: Safer CAR T cell therapy for solid tumors

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:

“Researchers at Memorial Sloan Kettering Cancer Center, led by Dr. David Scheinberg, have engineered a safer CAR T cell therapy for solid tumors! Traditional CAR T cells targeting GD2 caused fatal neurotoxicity by attacking normal brain tissue.

To overcome this, the team designed MEAT (Microenvironment Actuated T) cells, which activate only in the tumor environment by responding to P-selectin. This innovation prevents brain toxicity while maintaining antitumor effects, offering a promising path to expand CAR T therapy for solid tumors.”

Microenvironment actuated CAR T cells improve solid tumor efficacy without toxicity

Authors: Kristen C. Vogt, Qianqian Lin, James E. Han, Amy Laflin, Hendryck A. Gellineau, Daniel A. Heller, David A. Scheinberg

Yan Leyfman: Safer CAR T cell therapy for solid tumors

More posts featuring Yan Leyfman.